Tonix Pharmaceuticals names CEO's son as strategy chief
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 5.11 +0.01 (0.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.10 | 52 Week High | $7.95 | |||
| Open | $5.10 | 52 Week Low | $0.40 | |||
| Day High | $5.22 | P/E | N/A | |||
| Day Low | $5.04 | EPS | $-5.33 | |||
| Volume | 229,591 | |||||
